Interestingly, the authors showed that CELA2A plasma levels increase postprandially and in parallel with insulin levels, and that inherited loss-of-function of CELA2A can cause genetic clustering of the metabolic syndrome with early onset atherosclerosis and metabolic syndrome and affect plasma insulin and platelet activation in humans16. This evidence concerns the gene CELA2A and atherosclerosis.